These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 8217029)
1. Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats. McMahon EG; Palomo MA; Brown MA; Bertenshaw SR; Carter JS Am J Hypertens; 1993 Aug; 6(8):667-73. PubMed ID: 8217029 [TBL] [Abstract][Full Text] [Related]
2. Phosphoramidon blocks the pressor activity of big endothelin[1-39] and lowers blood pressure in spontaneously hypertensive rats. McMahon EG; Palomo MA; Moore WM J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S29-33. PubMed ID: 1725358 [TBL] [Abstract][Full Text] [Related]
3. Phosphoramidon inhibits the conversion of big ET-1 into ET-1 in the pithed rat and in isolated perfused rat kidneys. Verbeuren TJ; Mennecier P; Merceron D; Simonet S; de Nanteuil G; Vincent M; Laubie M J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S81-4. PubMed ID: 7510006 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of intrathecally administered endothelins and big endothelin-1 in conscious rats: receptor characterization and mechanism of action. Poulat P; D'Orléans-Juste P; de Champlain J; Yano M; Couture R Brain Res; 1994 Jun; 648(2):239-48. PubMed ID: 7522926 [TBL] [Abstract][Full Text] [Related]
6. Rhamnose moiety of phosphoramidon is not required for in vivo inhibition of endothelin converting enzyme. Pollock DM; Shiosaki K; Sullivan GM; Opgenorth TJ Biochem Biophys Res Commun; 1992 Jul; 186(2):1146-50. PubMed ID: 1497648 [TBL] [Abstract][Full Text] [Related]
7. Big-endothelin-1 contracts rat isolated uterus via a phosphoramidon-sensitive endothelin ETA receptor-mediated mechanism. Rae GA; Calixto JB; D'Orléans-Juste P Eur J Pharmacol; 1993 Aug; 240(2-3):113-9. PubMed ID: 8243532 [TBL] [Abstract][Full Text] [Related]
8. Disparate effects of phosphoramidon on blood pressure in SHR and DOCA-salt hypertensive rats. Vemulapalli S; Watkins RW; Brown A; Cook J; Bernardino V; Chiu PJ Life Sci; 1993; 53(10):783-93. PubMed ID: 8355566 [TBL] [Abstract][Full Text] [Related]
9. Structure activity relationship of phosphoramidon derivatives for in vivo endothelin-converting-enzyme inhibition. Bigaud M; Hauss B; Schalk C; Jauch MF; D'Orchymont H Fundam Clin Pharmacol; 1994; 8(2):155-61. PubMed ID: 8020872 [TBL] [Abstract][Full Text] [Related]
10. Effects of the ECE/NEP inhibitor CGS 34225 on the big ET-1-induced pressor response and plasma atrial natriuretic peptide concentration in conscious rats. Trapani AJ; Beil ME; Bruseo CW; Fink CA; Hoyer D; Savage P; Jeng AY Clin Sci (Lond); 2002 Aug; 103 Suppl 48():102S-106S. PubMed ID: 12193065 [TBL] [Abstract][Full Text] [Related]
11. Differences in potency of big endothelin-1-induced pressor action in rat isolated perfused mesenteric artery, hindquarter and lung. Hisaki K; Matsumura Y; Fujita K; Maekawa H; Takaoka M; Morimoto S Life Sci; 1994; 54(4):275-80. PubMed ID: 8289588 [TBL] [Abstract][Full Text] [Related]
12. A role for endothelin in bicuculline-induced neurogenic pulmonary oedema in rats. Herbst C; Tippler B; Shams H; Simmet T Br J Pharmacol; 1995 Jul; 115(5):753-60. PubMed ID: 8548173 [TBL] [Abstract][Full Text] [Related]
13. Pressor and pulmonary responses to ET-1(1-31) in guinea-pigs. Honoré JC; Plante M; Bkaily G; Rae GA; D'Orléans-Juste P Br J Pharmacol; 2002 Jul; 136(6):819-28. PubMed ID: 12110606 [TBL] [Abstract][Full Text] [Related]
14. ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney. Pollock DM; Opgenorth TJ Br J Pharmacol; 1994 Mar; 111(3):729-32. PubMed ID: 8019752 [TBL] [Abstract][Full Text] [Related]
15. BQ-123, a selective endothelin subtype A-receptor antagonist, lowers blood pressure in different rat models of hypertension. Douglas SA; Gellai M; Ezekiel M; Ohlstein EH J Hypertens; 1994 May; 12(5):561-7. PubMed ID: 7930556 [TBL] [Abstract][Full Text] [Related]
16. Phosphoramidon-sensitive conversion of big endothelin-1 and degradation of endothelin-1 in rat kidney. Fujita K; Matsumura Y; Kita S; Hisaki K; Takaoka M; Morimoto S Hypertension; 1994 Aug; 24(2):227-33. PubMed ID: 8039848 [TBL] [Abstract][Full Text] [Related]
17. In vivo characterization of a phosphoramidon-sensitive endothelin-converting enzyme in the rat. Pollock DM; Divish BJ; Milicic I; Novosad EI; Burres NS; Opgenorth TJ Eur J Pharmacol; 1993 Feb; 231(3):459-64. PubMed ID: 8449237 [TBL] [Abstract][Full Text] [Related]
18. Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors. Love MP; Haynes WG; Gray GA; Webb DJ; McMurray JJ Circulation; 1996 Nov; 94(9):2131-7. PubMed ID: 8901663 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the contractile and relaxant action of the endothelin-1 precursor, big endothelin-1, in the isolated rat basilar artery. Schilling L; Vatter H; Mursch K; Ehrenreich H; Schmiedek P Peptides; 2000 Jan; 21(1):91-9. PubMed ID: 10704724 [TBL] [Abstract][Full Text] [Related]
20. Endothelin-1 action via endothelin receptors is a primary mechanism modulating retinal circulatory response to hyperoxia. Takagi C; King GL; Takagi H; Lin YW; Clermont AC; Bursell SE Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2099-109. PubMed ID: 8814149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]